JORBIAN Trademark

Trademark Overview


On Friday, July 29, 2022, a trademark application was filed for JORBIAN with the United States Patent and Trademark Office. The USPTO has given the JORBIAN trademark a serial number of 97526370. The federal status of this trademark filing is REGISTERED as of Tuesday, September 5, 2023. This trademark is owned by Glaxo Group Limited. The JORBIAN trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
jorbian

General Information


Serial Number97526370
Word MarkJORBIAN
Filing DateFriday, July 29, 2022
Status700 - REGISTERED
Status DateTuesday, September 5, 2023
Registration Number7156769
Registration DateTuesday, September 5, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2023

Trademark Statements


Goods and ServicesVaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 20, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Tuesday, September 5, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 5, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, July 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 12, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 12, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 20, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 20, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 31, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 16, 2023ASSIGNED TO EXAMINER
Saturday, August 20, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 2, 2022NEW APPLICATION ENTERED